It has previously been demonstrated that CFTR-mediated Cl− secretion measurement in rectal biopsies is a reliable predictive biomarker for both the prognosis and diagnosis of CF23 and a robust method to assess the in vivo efficacy of CFTR modulators in CF patients undergoing in vivo treatment.35 This evidence concerns the gene CFTR and cystic fibrosis.